Yes, 12.5% of revenues (not profit) might be the typical ball park for licensing royalties
The margins are typically very good on drug manufacturing, its the process of getting successful trials and regulatory approval that make commercial development so expensive.
- Forums
- ASX - By Stock
- KZA
- Thank you to management!
Thank you to management!, page-21
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online